University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

Not Applicable

Completed

Conditions: Ovarian Cancer
Steroid Cell Tumor, Malignant

Interventions: Drug: Erdafitinib

First Posted Date: 2024-03-25

Last Posted Date: 2024-03-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT06328491

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders

Not Applicable

Not yet recruiting

Conditions: Ehlers-Danlos Syndrome
Hypermobility Syndrome
Irritable Bowel Syndrome
Gastrointestinal Dysfunction

Interventions: Other: Standard Medical Therapy
Behavioral: Gut-directed hypnotherapy

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 74

Registration Number: NCT06325345

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Pilot Trial of Virtual and In-person STEP2

Not Applicable

Not yet recruiting

Conditions: Oncology

Interventions: Behavioral: Virtual and in-person Symptom screening with Targeted Early Palliative care (STEP2)

First Posted Date: 2024-03-22

Last Posted Date: 2024-08-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT06326554

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

Recruiting

Conditions: Cardiovascular Surgical Procedures
Albumin

First Posted Date: 2024-03-21

Last Posted Date: 2024-12-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 500

Registration Number: NCT06322537

Locations: 🇨🇦
Royal Columbian Hospital, New Westminster, British Columbia, Canada
🇨🇦
Vancouver General Hospital, Vancouver,, British Columbia, Canada
🇨🇦
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

and more 7 locations

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Phase 2

Recruiting

Conditions: Melanoma Stage IV
Cutaneous Melanoma
Mucosal Melanoma

Interventions: Drug: Nivolumab
Drug: Opdualag

First Posted Date: 2024-03-19

Last Posted Date: 2024-10-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 54

Registration Number: NCT06319196

Locations: 🇨🇦
UHN- Princess Margaret Cancer Center, Toronto, Ontario, Canada

Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

Phase 2

Not yet recruiting

Conditions: Chronic Iron Deficiency Anaemia
Cardiac Surgery

Interventions: Drug: Monoferric Injectable Product
Other: 0.9% sodium chloride solution

First Posted Date: 2024-03-01

Last Posted Date: 2024-07-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT06287619

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
Toronto General Hospital - University Health Network, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Umbrella Study for Single Patient Treatments in Oncology

Recruiting

Conditions: Rare Diseases
Advanced Cancer

Interventions: Other: Patient-specific treatments

First Posted Date: 2024-02-29

Last Posted Date: 2024-02-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 400

Registration Number: NCT06285500

Locations: 🇨🇦
University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

ODYSSEE Kidney Health Trial

Not Applicable

Recruiting

Conditions: Chronic Kidney Diseases

Interventions: Behavioral: ODYSSEE-KH

First Posted Date: 2024-02-23

Last Posted Date: 2024-12-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 344

Registration Number: NCT06274710

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process

Not Applicable

Recruiting

Conditions: Prostate Cancer
Breast Cancer

Interventions: Other: Remote monitoring PROs

First Posted Date: 2024-02-23

Last Posted Date: 2024-10-17

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 124

Registration Number: NCT06274892

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Genetic: Liquid Biopsy
Device: Positron Emission Mammography (PEM)

First Posted Date: 2024-02-20

Last Posted Date: 2024-09-30

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06268405

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy